or
forgot password

Cyberknife Precision Radiation Delivery System for Tumors of the Spine


Phase 1/Phase 2
5 Years
N/A
Not Enrolling
Both
Spinal Cord Cancer, Brain (Nervous System) Cancers

Thank you

Trial Information

Cyberknife Precision Radiation Delivery System for Tumors of the Spine


Inclusion Criteria:

- Intra-axial, extra-axial, or vertebral spinal lesion

- Age > 5

- Histologic confirmation of malignant primary lesion or radiographic diagnosis of
benign or vascular spinal lesion

- No rapidly deteriorating symptoms of spinal cord compression

- No instability of the spine

- Life expectancy > 6 months

Exclusion Criteria:- Patients without tumors of the spine

- Patients younger than 5 years old

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions

Outcome Time Frame:

completed

Safety Issue:

No

Principal Investigator

Iris Catrice Gibbs

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

SPN0001

NCT ID:

NCT00185666

Start Date:

May 2002

Completion Date:

May 2006

Related Keywords:

  • Spinal Cord Cancer
  • Brain (Nervous System) Cancers
  • Spinal Cord Diseases
  • Central Nervous System Neoplasms

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317